ArticleFrontiers in medicine2026
The vasoactive-age adjusted sepsis-induced coagulopathy score predicts 28-day new-onset multiple organ dysfunction syndrome in patients with sepsis: a single-centre retrospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early identification of sepsis patients at high risk of multiple organ dysfunction syndrome (MODS) remains challenging. The Sepsis-Induced Coagulopathy (SIC) score does not incorporate age or vasopressor use, both strongly associated with organ failure progression. The Vasoactive-Age adjusted SIC (VAS) score integrates these dimensions, but its predictive value for new-onset MODS has not been systematically evaluated. Methods: This single-centre retrospective cohort study enrolled 495 adult sepsis patients (Sepsis-3.0 criteria) admitted between January 2019 and June 2023. Baseline VAS, SIC, Sequential Organ Failure Assessment (SOFA), 24-h worst SOFA (SOFA-2), Acute Physiology and Chronic Health Evaluation II (APACHE II), and quick SOFA (qSOFA) scores were calculated. The primary outcome was 28-day new-onset MODS. Predictive performance was compared using the area under the receiver operating characteristic curve (AUC) and the DeLong method. Cumulative incidence was estimated with Fine-Gray competing-risk models. Independent predictors were identified by multivariable Cox regression. Net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis quantified incremental value. A nomogram was internally validated by 1,000-bootstrap resampling. Results: New-onset MODS occurred in 148 patients (29.9%). The VAS score yielded an AUC of 0.777 [95% confidence interval (CI) 0.755-0.841], significantly higher than SIC (0.708, Conclusion: The VAS score is a simple bedside tool that independently predicts 28-day new-onset MODS in sepsis, outperforming the SIC score and matching SOFA with fewer parameters. Combination with circulating biomarkers and dynamic ΔVAS monitoring provides additional prognostic value and supports its integration into early sepsis risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.